Chinese BCI Firm BrainXBot Hails Breakthrough in Mind Control of Black Myth: Wukong, Smart Devices
Qian Tongxin
DATE:  Apr 18 2025
/ SOURCE:  Yicai
Chinese BCI Firm BrainXBot Hails Breakthrough in Mind Control of Black Myth: Wukong, Smart Devices Chinese BCI Firm BrainXBot Hails Breakthrough in Mind Control of Black Myth: Wukong, Smart Devices

(Yicai) April 18 -- BrainXBot said that a patient implanted with the Chinese brain-computer interface firm's self-developed invasive device has managed to play video games, including Black Myth: Wukong and Honor of Kings, as well as carry out "dialogue" with and control smart devices using his mind.

The 19-year-old patient with epilepsy entered an Investigator-Initiated Trial after undergoing surgery at Huashan Hospital in Shanghai, BrainXBot said yesterday. After almost 20 hours of training, he was able to precisely control well-known classic and larger, more complex video games using his thoughts, the company noted.

In addition, the BCI allowed him to surf the internet smoothly, operate various apps, control a smart wheelchair, and manage smart home devices, BrainXBot pointed out.

The patient achieved 4.07 bits per second cursor brain control performance after about 20 hours of training, a result close to the 4.6 BPS the first subject of Elon Musk's Neuralink achieved after 60 hours, noted Zhou Zhitao, a researcher at the Chinese Academy of Sciences' Shanghai Institute of Microsystem and Information Technology.

"The reaction speed is close to the operation level of a normal person using a mouse," Zhou said. "It effectively verifies the feasibility of BCI technology in complex scenarios and offers hope for the functional reconstruction of patients with motor disabilities."

BrainXBot plans to complete the clinical registration of its BCI as a Class III medical device within three years and will accelerate clinical trial work this year, founder Tao Hu said at the start of the year.

BrainXBot plans to go public on Shanghai's Nasdaq-style Star Market or the Hong Kong market around 2028, Chief Executive Peng Lei said in an interview with Yicai last June.

Established at the end of 2021, BrainXBot has well-known investors, including Shanda Group and HongShan Capital Group.

Editors: Tang Shihua, Martin Kadiev

Follow Yicai Global on
Keywords:   Investigator Initiated Clinical Trial,Brain-Machine Interface,Brain-Computer Interface Developer,NeuroXess